Last 12 months
Inside the activity.
2 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2022 Filed Feb 15, 2022 02:10 UTC |
Pinto AlexisChief Legal Officer
|
SaleCommon Stock | 77 | $50.75 | $3,907.53 |
DisclosureSEC source: 0001725160-22-000034 · wf-form4_164489099132680.xml · nonDerivative · entry 3 Pinto Alexis · CIK 0001819302 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,240 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units. F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.58 to $50.81. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 02:10 UTC |
Pinto AlexisChief Legal Officer
|
SaleCommon Stock | 614 | $50.16 | $30,800.82 |
DisclosureSEC source: 0001725160-22-000034 · wf-form4_164489099132680.xml · nonDerivative · entry 2 Pinto Alexis · CIK 0001819302 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,317 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.58 to $50.56. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 02:08 UTC |
SUN ANTHONY YDirector · President & CEO
|
SaleCommon Stock | 525 | $50.75 | $26,642.28 |
DisclosureSEC source: 0001725160-22-000031 · wf-form4_164489087350121.xml · nonDerivative · entry 3 SUN ANTHONY Y · CIK 0001377952 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,217,473 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units. F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.58 to $50.81. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 02:08 UTC |
SUN ANTHONY YDirector · President & CEO
|
SaleCommon Stock | 4,208 | $50.16 | $211,090.95 |
DisclosureSEC source: 0001725160-22-000031 · wf-form4_164489087350121.xml · nonDerivative · entry 2 SUN ANTHONY Y · CIK 0001377952 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,217,998 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.58 to $50.56. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 02:09 UTC |
Gallagher CamDirector
|
SaleCommon Stock | 4,850 | $50.17 | $243,340.02 |
DisclosureSEC source: 0001725160-22-000032 · wf-form4_164489091255122.xml · nonDerivative · entry 5 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,813 F6 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021. F7 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.77 to $50.67. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 02:09 UTC |
Gallagher CamDirector
|
SaleCommon Stock | 259 | $50.75 | $13,143.52 |
DisclosureSEC source: 0001725160-22-000032 · wf-form4_164489091255122.xml · nonDerivative · entry 4 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,663 F3 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units. F5 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.58 to $50.81. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 02:09 UTC |
Gallagher CamDirector
|
SaleCommon Stock | 2,079 | $50.16 | $104,291.37 |
DisclosureSEC source: 0001725160-22-000032 · wf-form4_164489091255122.xml · nonDerivative · entry 3 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,922 F3 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units. F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.58 to $50.56. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:11 UTC |
Bunker Kevin D.Chief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 52,745 | $0.00 Strike: $52.61 | $0.00 |
DisclosureSEC source: 0001725160-22-000036 · wf-form4_164489104767793.xml · derivative · entry 10 Bunker Kevin D. · CIK 0001807484 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,745 Underlying: Common Stock · 52,745 shares Expires 2032-02-09 F12 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:11 UTC |
Bunker Kevin D.Chief Operating Officer
|
SaleCommon Stock | 1,239 | $54.96 | $68,096.93 |
DisclosureSEC source: 0001725160-22-000036 · wf-form4_164489104767793.xml · nonDerivative · entry 5 Bunker Kevin D. · CIK 0001807484 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 170,000 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021. F7 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $54.72 to $55.41. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:11 UTC |
Bunker Kevin D.Chief Operating Officer
|
SaleCommon Stock | 3,321 | $54.20 | $180,002.52 |
DisclosureSEC source: 0001725160-22-000036 · wf-form4_164489104767793.xml · nonDerivative · entry 4 Bunker Kevin D. · CIK 0001807484 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 171,239 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021. F6 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $53.71 to $54.68. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:11 UTC |
Bunker Kevin D.Chief Operating Officer
|
SaleCommon Stock | 3,074 | $53.19 | $163,501.76 |
DisclosureSEC source: 0001725160-22-000036 · wf-form4_164489104767793.xml · nonDerivative · entry 3 Bunker Kevin D. · CIK 0001807484 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 174,560 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021. F5 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $52.69 to $53.68. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:11 UTC |
Bunker Kevin D.Chief Operating Officer
|
SaleCommon Stock | 2,366 | $52.15 | $123,393.76 |
DisclosureSEC source: 0001725160-22-000036 · wf-form4_164489104767793.xml · nonDerivative · entry 2 Bunker Kevin D. · CIK 0001807484 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 177,634 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $51.68 to $52.67. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:11 UTC |
Bunker Kevin D.Chief Operating Officer
|
GrantCommon Stock | 22,481 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-22-000036 · wf-form4_164489104767793.xml · nonDerivative · entry 1 Bunker Kevin D. · CIK 0001807484 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 768,798 F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 02:10 UTC |
Voliotis DimitrisSVP, Clinical Development
|
GrantStock Option (Right to Buy) · Derivative | 24,234 | $0.00 Strike: $52.61 | $0.00 |
DisclosureSEC source: 0001725160-22-000035 · wf-form4_164489102664442.xml · derivative · entry 4 Voliotis Dimitris · CIK 0001807910 · SVP, Clinical Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,234 Underlying: Common Stock · 24,234 shares Expires 2032-02-09 F5 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 02:10 UTC |
Voliotis DimitrisSVP, Clinical Development
|
GrantCommon Stock | 10,329 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-22-000035 · wf-form4_164489102664442.xml · nonDerivative · entry 1 Voliotis Dimitris · CIK 0001807910 · SVP, Clinical Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,579 F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 02:09 UTC |
Epperly Melissa B,Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 38,489 | $0.00 Strike: $52.61 | $0.00 |
DisclosureSEC source: 0001725160-22-000033 · wf-form4_164489096835537.xml · derivative · entry 2 Epperly Melissa B, · CIK 0001807359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,489 Underlying: Common Stock · 38,489 shares Expires 2032-02-09 F2 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 02:09 UTC |
Epperly Melissa B,Chief Financial Officer
|
GrantCommon Stock | 16,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-22-000033 · wf-form4_164489096835537.xml · nonDerivative · entry 1 Epperly Melissa B, · CIK 0001807359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,407 F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 02:10 UTC |
Pinto AlexisChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 38,489 | $0.00 Strike: $52.61 | $0.00 |
DisclosureSEC source: 0001725160-22-000034 · wf-form4_164489099132680.xml · derivative · entry 4 Pinto Alexis · CIK 0001819302 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,489 Underlying: Common Stock · 38,489 shares Expires 2032-02-09 F5 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 02:10 UTC |
Pinto AlexisChief Legal Officer
|
GrantCommon Stock | 16,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-22-000034 · wf-form4_164489099132680.xml · nonDerivative · entry 1 Pinto Alexis · CIK 0001819302 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,931 F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 02:08 UTC |
SUN ANTHONY YDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 118,319 | $0.00 Strike: $52.61 | $0.00 |
DisclosureSEC source: 0001725160-22-000031 · wf-form4_164489087350121.xml · derivative · entry 8 SUN ANTHONY Y · CIK 0001377952 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,319 Underlying: Common Stock · 118,319 shares Expires 2032-02-09 F7 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 02:08 UTC |
SUN ANTHONY YDirector · President & CEO
|
GrantCommon Stock | 50,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-22-000031 · wf-form4_164489087350121.xml · nonDerivative · entry 1 SUN ANTHONY Y · CIK 0001377952 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,222,206 F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 02:09 UTC |
Gallagher CamDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,245 | $0.00 Strike: $52.61 | $0.00 |
DisclosureSEC source: 0001725160-22-000032 · wf-form4_164489091255122.xml · derivative · entry 6 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,245 Underlying: Common Stock · 19,245 shares Expires 2032-02-09 F8 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 02:09 UTC |
Gallagher CamDirector
|
GrantCommon Stock | 7,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-22-000032 · wf-form4_164489091255122.xml · nonDerivative · entry 2 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,001 F2 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in full on the first anniversary of the grant date. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 02:09 UTC |
Gallagher CamDirector
|
GrantCommon Stock | 8,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-22-000032 · wf-form4_164489091255122.xml · nonDerivative · entry 1 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,406 F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date. Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 02:53 UTC |
Gallagher CamDirector
|
SaleCommon Stock | 1,250 | $54.35 | $67,940.50 |
DisclosureSEC source: 0001725160-22-000019 · wf-form4_164428878233215.xml · nonDerivative · entry 3 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,203 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021. F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $54.20 to $54.50. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 02:53 UTC |
Gallagher CamDirector
|
SaleCommon Stock | 6,460 | $53.51 | $345,686.23 |
DisclosureSEC source: 0001725160-22-000019 · wf-form4_164428878233215.xml · nonDerivative · entry 2 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388,453 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $53.03 to $54.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 02:53 UTC |
Gallagher CamDirector
|
SaleCommon Stock | 2,290 | $52.77 | $120,847.19 |
DisclosureSEC source: 0001725160-22-000019 · wf-form4_164428878233215.xml · nonDerivative · entry 1 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,913 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $52.02 to $52.97. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 01:03 UTC |
SUN ANTHONY YDirector · President & CEO
|
SaleCommon Stock | 2,343 | $58.29 | $136,578.86 |
DisclosureSEC source: 0001725160-22-000017 · wf-form4_164393660436349.xml · nonDerivative · entry 6 SUN ANTHONY Y · CIK 0001377952 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,171,775 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021. F6 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $58.16 to $58.53. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 01:03 UTC |
SUN ANTHONY YDirector · President & CEO
|
SaleCommon Stock | 8,128 | $57.87 | $470,386.87 |
DisclosureSEC source: 0001725160-22-000017 · wf-form4_164393660436349.xml · nonDerivative · entry 5 SUN ANTHONY Y · CIK 0001377952 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,174,118 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021. F5 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $57.16 to $58.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 01:03 UTC |
SUN ANTHONY YDirector · President & CEO
|
SaleCommon Stock | 100 | $59.31 | $5,931.00 |
DisclosureSEC source: 0001725160-22-000017 · wf-form4_164393660436349.xml · nonDerivative · entry 4 SUN ANTHONY Y · CIK 0001377952 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,182,246 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 01:03 UTC |
SUN ANTHONY YDirector · President & CEO
|
SaleCommon Stock | 2,828 | $58.59 | $165,684.60 |
DisclosureSEC source: 0001725160-22-000017 · wf-form4_164393660436349.xml · nonDerivative · entry 3 SUN ANTHONY Y · CIK 0001377952 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,182,346 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021. F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $58.24 to $59.21. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 01:03 UTC |
SUN ANTHONY YDirector · President & CEO
|
SaleCommon Stock | 3,419 | $57.63 | $197,027.74 |
DisclosureSEC source: 0001725160-22-000017 · wf-form4_164393660436349.xml · nonDerivative · entry 2 SUN ANTHONY Y · CIK 0001377952 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,185,174 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $57.21 to $58.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 01:03 UTC |
SUN ANTHONY YDirector · President & CEO
|
SaleCommon Stock | 4,124 | $56.81 | $234,282.79 |
DisclosureSEC source: 0001725160-22-000017 · wf-form4_164393660436349.xml · nonDerivative · entry 1 SUN ANTHONY Y · CIK 0001377952 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,188,593 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $56.21 to $57.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 20, 2022 Filed Jan 20, 2022 19:14 UTC |
Bunker Kevin D.Chief Operating Officer
|
SaleCommon Stock | 710 | $61.29 | $43,518.10 |
DisclosureSEC source: 0001725160-22-000014 · wf-form4_164272407350854.xml · nonDerivative · entry 3 Bunker Kevin D. · CIK 0001807484 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 180,000 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021. F5 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $61.12 to $61.64. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any. Read SEC document |
| January 20, 2022 Filed Jan 20, 2022 19:14 UTC |
Bunker Kevin D.Chief Operating Officer
|
SaleCommon Stock | 6,537 | $60.20 | $393,505.17 |
DisclosureSEC source: 0001725160-22-000014 · wf-form4_164272407350854.xml · nonDerivative · entry 2 Bunker Kevin D. · CIK 0001807484 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 180,710 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021. F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $59.77 to $60.74. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any. Read SEC document |
| January 20, 2022 Filed Jan 20, 2022 19:14 UTC |
Bunker Kevin D.Chief Operating Officer
|
SaleCommon Stock | 2,753 | $59.17 | $162,888.68 |
DisclosureSEC source: 0001725160-22-000014 · wf-form4_164272407350854.xml · nonDerivative · entry 1 Bunker Kevin D. · CIK 0001807484 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 187,247 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $58.66 to $59.56. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 00:15 UTC |
Voliotis DimitrisSVP, Clinical Development
|
Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001725160-22-000015 · wf-form4_164272409240773.xml · derivative · entry 15 Voliotis Dimitris · CIK 0001807910 · SVP, Clinical Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,949 Underlying: Common Stock · 10,000 shares Expires 2030-03-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2021. F11 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on March 25, 2021 and vests in equal monthly installments thereafter until March 25, 2024. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 00:15 UTC |
Voliotis DimitrisSVP, Clinical Development
|
SaleCommon Stock | 1,657 | $61.21 | $101,419.17 |
DisclosureSEC source: 0001725160-22-000015 · wf-form4_164272409240773.xml · nonDerivative · entry 12 Voliotis Dimitris · CIK 0001807910 · SVP, Clinical Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2021. F10 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $61.01 to $61.61. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 00:15 UTC |
Voliotis DimitrisSVP, Clinical Development
|
SaleCommon Stock | 8,343 | $60.52 | $504,904.18 |
DisclosureSEC source: 0001725160-22-000015 · wf-form4_164272409240773.xml · nonDerivative · entry 11 Voliotis Dimitris · CIK 0001807910 · SVP, Clinical Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,907 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2021. F9 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $60.00 to $60.95. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 00:15 UTC |
Voliotis DimitrisSVP, Clinical Development
|
Exercise / conversionCommon Stock | 10,000 | $18.00 | $180,000.00 |
DisclosureSEC source: 0001725160-22-000015 · wf-form4_164272409240773.xml · nonDerivative · entry 10 Voliotis Dimitris · CIK 0001807910 · SVP, Clinical Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2021. Read SEC document |
| January 19, 2022 Filed Jan 21, 2022 00:15 UTC |
Voliotis DimitrisSVP, Clinical Development
|
Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001725160-22-000015 · wf-form4_164272409240773.xml · derivative · entry 14 Voliotis Dimitris · CIK 0001807910 · SVP, Clinical Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,949 Underlying: Common Stock · 10,000 shares Expires 2030-03-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2021. F11 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on March 25, 2021 and vests in equal monthly installments thereafter until March 25, 2024. Read SEC document |
| January 19, 2022 Filed Jan 21, 2022 00:15 UTC |
Voliotis DimitrisSVP, Clinical Development
|
SaleCommon Stock | 555 | $62.24 | $34,540.54 |
DisclosureSEC source: 0001725160-22-000015 · wf-form4_164272409240773.xml · nonDerivative · entry 9 Voliotis Dimitris · CIK 0001807910 · SVP, Clinical Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2021. F8 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $62.15 to $62.41. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 19, 2022 Filed Jan 21, 2022 00:15 UTC |
Voliotis DimitrisSVP, Clinical Development
|
SaleCommon Stock | 1,556 | $61.51 | $95,707.23 |
DisclosureSEC source: 0001725160-22-000015 · wf-form4_164272409240773.xml · nonDerivative · entry 8 Voliotis Dimitris · CIK 0001807910 · SVP, Clinical Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,805 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2021. F7 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $61.09 to $61.94. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 19, 2022 Filed Jan 21, 2022 00:15 UTC |
Voliotis DimitrisSVP, Clinical Development
|
SaleCommon Stock | 7,889 | $60.55 | $477,682.89 |
DisclosureSEC source: 0001725160-22-000015 · wf-form4_164272409240773.xml · nonDerivative · entry 7 Voliotis Dimitris · CIK 0001807910 · SVP, Clinical Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,361 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2021. F6 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $60.07 to $61.05. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 19, 2022 Filed Jan 21, 2022 00:15 UTC |
Voliotis DimitrisSVP, Clinical Development
|
Exercise / conversionCommon Stock | 10,000 | $18.00 | $180,000.00 |
DisclosureSEC source: 0001725160-22-000015 · wf-form4_164272409240773.xml · nonDerivative · entry 6 Voliotis Dimitris · CIK 0001807910 · SVP, Clinical Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2021. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 00:21 UTC |
Gallagher CamDirector
|
SaleCommon Stock | 1,300 | $64.66 | $84,062.03 |
DisclosureSEC source: 0001725160-22-000011 · wf-form4_164263808105131.xml · nonDerivative · entry 4 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,203 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021. F5 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $64.23 to $65.19. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 00:21 UTC |
Gallagher CamDirector
|
SaleCommon Stock | 1,842 | $63.45 | $116,868.64 |
DisclosureSEC source: 0001725160-22-000011 · wf-form4_164263808105131.xml · nonDerivative · entry 3 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,503 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021. F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $63.09 to $63.92. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 00:21 UTC |
Gallagher CamDirector
|
SaleCommon Stock | 3,424 | $62.37 | $213,544.61 |
DisclosureSEC source: 0001725160-22-000011 · wf-form4_164263808105131.xml · nonDerivative · entry 2 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,345 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $62.01 to $62.93. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 00:21 UTC |
Gallagher CamDirector
|
SaleCommon Stock | 3,434 | $61.71 | $211,900.46 |
DisclosureSEC source: 0001725160-22-000011 · wf-form4_164263808105131.xml · nonDerivative · entry 1 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,769 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $61.01 to $62.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 00:15 UTC |
Voliotis DimitrisSVP, Clinical Development
|
Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001725160-22-000015 · wf-form4_164272409240773.xml · derivative · entry 13 Voliotis Dimitris · CIK 0001807910 · SVP, Clinical Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,949 Underlying: Common Stock · 10,000 shares Expires 2030-03-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2021. F11 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on March 25, 2021 and vests in equal monthly installments thereafter until March 25, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.